JAMP Guanfacine XR 1 mg: Foreign tablets
Is your product affected? Check the DIN and lot number on your package against the list in Health Canada's official notice.
See affected DINs and lot numbers on Health Canada ↗Why it was recalled
Product safety
What you should do
- Check your or your child's pill bottle of JAMP Guanfacine XR 1 mg tablets to ensure it contains only 1 mg white, round tablets. If it contains any JAMP Guanfacine XR 4 mg green, oval tablets, or if you are unsure, return it to your pharmacy. Your pharmacist will check it and provide you with a replacement if needed.
- Contact a health care professional immediately if you or your child are experiencing signs and symptoms of overdose.
- Contact JAMP Pharma Corporation by calling toll-free at 1-866-399-9091, extension 501, or by email at custjamp@jamppharma.com, if you have questions about this recall.
- Report any health product-related side effects or complaints to Health Canada.
- Additional information for health professionals:Health care professionals, such as pharmacists, should check bottles of Guanfacine XR 1 mg tablets before dispensing and report any unusual bottles or other issue to the company and to Health Canada.
Other Recent Recalls
PDP-DIPHENHYDRAMINE
PDP-DIPHENHYDRAMINE 25 MG and 50 MG CAPSULES: Out-of-specification (Impurity)
Type II2026-11-09
Moderate health risk
Unauthorized injectable peptide and non-peptide drugs
Health Canada warns about contaminated unauthorized injectable peptides and non-peptide drugs
2026-11-06
ANTICOAGULANT SODIUM CITRATE SOLUTION, USP
ANTICOAGULANT SODIUM CITRATE SOLUTION, USP 4g/100mL and Potential Bag Leaks
2026-11-03
Recall data is sourced from Health Canada's Recalls and Safety Alerts open dataset. MedShort.ca is an independent tracking tool and does not provide medical advice — for questions about this recall, contact the manufacturer or your pharmacist, or read the full notice linked above.